2 results
Not approvedWill not start
Primary objective: To document clinical utility and distribution of indications for short-term pancreatic stenting and stent type preference by indication at tertiary referral centers with expertise in pancreatic endotherapy.Detailed objective: To…
Approved WMORecruiting
Primary:To determine the safety and tolerability and to establish a preliminary recommended Phase 2 dose (RP2D) of MK-5890 when used as monotherapy and in combination with pembrolizumab in the dose escalation and confirmation phase and the dose…